Short-term response to alemtuzumab in CD52-positive secondary histiocytic sarcoma in a child: Is it time to consider new targets?-Reference-Cited by-同舟云学术

Short-term response to alemtuzumab in CD52-positive secondary histiocytic sarcoma in a child: Is it time to consider new targets?

Published:2020-09-08 Issue:1 Volume:38 Page:89-96
ISSN:0888-0018
Container-title:Pediatric Hematology and Oncology
language:en
Short-container-title:Pediatric Hematology and Oncology

Author:

Valera Elvis Terci¹,Brassesco María Sol²,Reis Maristella Bergamo Francisco dos¹,Maggioni Gilberto³,Guerino-Cunha Renato Luiz⁴,Grecco Carlos Eduardo⁴,Jr. Jorge Elias⁵,Kato Mery⁶,Tone Luiz Gonzaga¹

Affiliation:

1. Department of Pediatrics, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil

2. Department of Biology, Faculty of Philosophy, Sciences and Letters at Ribeirão Preto, University of São Paulo, Brazil

3. Laboratório Dr. Prates, Ribeirão Preto, Brazil

4. Bone Marrow Transplantation and Cellular Therapy Unit, Department of Medical Imaging, Hematology and Clinical Oncology, Ribeirão Preto Medical School, University of São Paulo Brazil

5. Department of Medical Imaging, Hematology and Clinical Oncology, Ribeirão Preto Medical School, University of São Paulo Brazil

6. Diagnostic of Nuclear Medicine - DIMEN - Ribeirão Preto, Brazil

Publisher

Informa UK Limited

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

https://www.tandfonline.com/doi/pdf/10.1080/08880018.2020.1811438

Reference40 articles.

1. Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages

2. Clinicopathologic Features of Histiocytic Lesions following ALL, with a Review of the Literature

3. Shorter Maintenance Therapy in Childhood Acute Lymphoblastic Leukemia: The Experience of the Prospective, Randomized Brazilian GBTLI ALL-93 Protocol

4. Successful treatment of refractory metastatic histiocytic sarcoma with alemtuzumab

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. One Health: Therapies Targeting Genetic Variants in Human and Canine Histiocytic and Dendritic Cell Sarcomas;Veterinary and Comparative Oncology;2024-06-12